The EU initiatives RESTORE and CARAT are conducting a joint survey within our research networks to identify the most important technological, regulatory, clinical and ethical hurdles for translation of CAR T and ATMP into clinical application.
The short anonymous survey includes just 12 questions and will take roughly 7 minutes to complete. We would be very grateful if you took the time to fill in your answers, as the gathered information will be extremely helpful for our discussions with regulatory bodies and to design targeted support measures for better translation of ATMPs.
Click the link below to start the survey. Thanks a lot in advance for your participation!
On behalf of the CARAT and RESTORE teams
CARAT and RESTORE survey
Contact for the survey:
Dr. Michael Apel
Grants * Project Management * Cooperations Miltenyi Biotec B.V. & Co. KG Friedrich-Ebert-Str. 68
51429 Bergisch Gladbach, Germany
Phone +49 2204 8306-4236